Xtrackers FTSE Developed ex US Multifactor ETF (ARCA: DEEF)

Latest news for Xtrackers FTSE Developed ex US Multifactor ETF (ARCA:DEEF)

Xtrackers FTSE Developed ex US Comprehensive Factor ETF

Deutsche X-trackers FTSE Developed ex US Comprehensive Factor ETF

Industrials

Consumer Cyclical

Basic Materials

Financial Services

Consumer Defensive

Utilities

Energy

Technology

Communication Services

Healthcare

Real Estate

Other

The fund, using a passive or indexing investment approach, seeks investment results that correspond generally to the performance, before fees and expenses, of the Underlying Index, which is designed to track the equity market performance of companies in developed countries (except the United States) selected on the investment style criteria (factors) of quality, value, momentum, low volatility and size. The companies eligible for the Underlying Index are derived from its starting universe, the TSE Developed ex US Index, which is comprised of large- and mid-capitalization equity securities from developed markets (except the United States). The index provider, FTSE International Limited (Index Provider), selects companies for the Underlying Index using a proprietary rules-based multi-factor selection and weighting process designed to increase the Underlying Indexs exposure.

3i Group Plc

Jxtg Holdings Inc

Trelleborg Ab

Dcc Plc

Singapore Airlines Ltd

E.on Se Common Stock

Xtrackers FTSE Developed ex US Multifactor ETF

Long Ideas

News

Broad U.S. Equity ETFs

New ETFs

Small Cap

Trading Ideas

ETFs

DEEF

DEUS

Deutsche AM Adds Multi-Factor Small-Cap ETF

Emerging Market ETFs

New ETF Gets Comprehensive With Emerging Markets Exposure

Markets

BBBY

Multi-Factor Fun With Some New ETFs

Exane BNP Paribas analyst Thomas Poutrieux upgrades BILL Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>) from Neutral to Outperform and announces $90 price target.

Upgrades

Price Target

Analyst Ratings

BILL

Exane BNP Paribas Upgrades BILL Holdings to Outperform, Announces $90 Price Target

<a href="https://openai.com/index/introducing-openai-o1-preview/">https://openai.com/index/introducing-openai-o1-preview/</a>
&nbsp;
A new series of reasoning models for solving hard problems. Available starting 9.12
We've developed a new series of AI models designed to spend more time thinking before they respond. They can reason through complex tasks and solve harder problems than previous models in science, coding, and math. Today, we are releasing the first of this series in ChatGPT and our API. This is a preview and we expect regular updates and improvements. Alongside this release, we're also including <a href="https://openai.com/index/learning-to-reason-with-llms/">evaluations</a> for the next update, currently in development.
<h2>How it works</h2>
We trained these models to spend more time thinking through problems before they respond, much like a person would. Through training, they learn to refine their thinking process, try different strategies, and recognize their mistakes.&nbsp;
In our tests, the next model update performs similarly to PhD students on challenging benchmark tasks in physics, chemistry, and biology. We also found that it excels in math and coding. In a qualifying exam for the International Mathematics Olympiad (IMO), GPT-4o correctly solved only 13% of problems, while the reasoning model scored 83%. Their coding abilities were evaluated in contests and reached the 89th percentile in Codeforces competitions. You can read more about this in our <a href="https://openai.com/index/learning-to-reason-with-llms/">technical research post</a>.
As an early model, it doesn't yet have many of the features that make ChatGPT useful, like browsing the web for information and uploading files and images. For many common cases GPT-4o will be more capable in the near term.
But for complex reasoning tasks this is a significant advancement and represents a new level of AI capability. Given this, we are resetting the counter back to 1 and naming this series OpenAI o1.
<h2>Safety</h2>
As part of developing these new models, we have come up with a new safety training approach that harnesses their reasoning capabilities to make them adhere to safety and alignment guidelines. By being able to reason about our safety rules in context, it can apply them more effectively.&nbsp;
One way we measure safety is by testing how well our model continues to follow its safety rules if a user tries to bypass them (known as "jailbreaking"). On one of our hardest jailbreaking tests, GPT-4o scored 22 (on a scale of 0-100) while our o1-preview model scored 84. You can read more about this in the <a href="https://openai.com/index/openai-o1-system-card/">system card</a> and our <a href="https://openai.com/index/learning-to-reason-with-llms/">research post</a>.
To match the new capabilities of these models, we've bolstered our safety work, internal governance, and federal government collaboration. This includes rigorous testing and evaluations using our <a href="https://cdn.openai.com/openai-preparedness-framework-beta.pdf">Preparedness Framework(opens in a new window)</a>, best-in-class red teaming, and board-level review processes, including by our Safety &amp; Security Committee. To advance our commitment to AI safety, we recently formalized agreements with the U.S. and U.K. AI Safety Institutes. We've begun operationalizing these agreements, including granting the institutes early access to a research version of this model. This was an important first step in our partnership, helping to establish a process for research, evaluation, and testing of future models prior to and following their public release.
<h2>Whom it's for</h2>
These enhanced reasoning capabilities may be particularly useful if you're tackling complex problems in science, coding, math, and similar fields. For example, o1 can be used by healthcare researchers to annotate cell sequencing data, by physicists to generate complicated mathematical formulas needed for quantum optics, and by developers in all fields to build and execute multi-step workflows.&nbsp;

MSFT

'Introducing OpenAI o1-preview' - OpenAI

<a href="https://asia.nikkei.com/Business/Business-deals/MUFG-to-pause-talks-on-investing-in-Indian-nonbank#:~:text=Japan's%20largest%20financial%20group%20had,to%20expand%20its%20Indian%20business.">https://asia.nikkei.com/Business/Business-deals/MUFG-to-pause-talks-on-investing-in-Indian-nonbank#:~:text=Japan's%20largest%20financial%20group%20had,to%20expand%20its%20Indian%20business.</a>
&nbsp;
TOKYO -- Japan's Mitsubishi UFJ Financial Group will halt talks on acquiring shares in a nonbank financial company under India's HDFC Bank after an apparent failure to agree on the terms of a deal, Nikkei has learned.
Japan's largest financial group <a href="https://asia.nikkei.com/Business/Finance/Japan-s-MUFG-in-talks-to-invest-in-India-s-HDFC-Bank-unit">had proposed investing</a> 200 billion to 300 billion yen ($1.4 billion to $2.1 billion) to acquire around a 20% stake in HDB Financial Services.
 &nbsp;

Macro Economic Events

Global

Economics

INDA

MUFG

'MUFG To Pause Talks On Investing In Indian Nonbank; Japanese Financial Group Had Been Seeking Stake In HDFC Bank Unit' - Nikkei Asia

Xencor (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xncr#NASDAQ">XNCR</a>) shares rallied 10.5% in the last trading session to close at $21.13. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock&#39;s 19.8% gain over the past four weeks.
This jump in share price came after the company announced that it was floating a secondary issue of common stock, along with pre-funded warrants, to raise nearly $175 million in gross proceeds. Management intends to issue more than 6.6 million shares at $18 apiece, along with pre-funded warrants to buy an additional 3 million shares for $17.99 a warrant.
Xencor will likely use these funds to support its pipeline development. Last week, the company unveiled details on four new programs targeting autoimmune diseases.
This biotech developing antibodies for severe autoimmune/allergic diseases and cancer is expected to post quarterly loss of $1.01 per share in its upcoming report, which represents a year-over-year change of -152.5%. Revenues are expected to be $7.74 million, down 86.9% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Xencor, the consensus EPS estimate for the quarter has been revised 0.8% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn&#39;t usually translate into price appreciation. So, make sure to keep an eye on XNCR going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold).
Xencor belongs to the Zacks Medical - Drugs industry. Another stock from the same industry, USANA Health Sciences (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/usna#NYSE">USNA</a>), closed the last trading session 0.2% lower at $37.28. Over the past month, USNA has returned -3%.
For USANA Health, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.49. This represents a change of -17% from what the company reported a year ago. USANA Health currently has a Zacks Rank of #4 (Sell).
<a href="https://www.zacks.com/stock/news/2334996/xencor-xncr-surges-10-5-is-this-an-indication-of-further-gains?cid=CS-BENZ-FT-tale_of_the_tape|daily_price_change_5%-2334996">To read this article on Zacks.com click here.</a>

Biotech

Earnings

Management

General

USNA

XNCR

Xencor Surges 10.5%: Is This an Indication of Further Gains?

Goldman Sachs analyst Stephen Laszczyk maintains TKO Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKO#NYSE">TKO</a>) with a Buy and maintains $132 price target.

Goldman Sachs Maintains Buy on TKO Group Holdings, Maintains $132 Price Target

WIIM

Meiwu Technology shares are trading lower after the company received a Nasdaq notification letter regarding its bid price deficiency.

United States Steel (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/x#NYSE">X</a>) shares rallied 7% in the last trading session to close at $33.39. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock&#39;s 25.5% loss over the past four weeks.
U.S. Steel&#39;s stock popped on reports that a senior Nippon Steel executive traveled to Washington to meet with U.S. officials in a last-ditch effort to save Nippon Steel&#39;s proposed $14.9 billion takeover of U.S. Steel following reports a week ago that the Biden administration was preparing to block the deal.
This steel maker is expected to post quarterly earnings of $0.37 per share in its upcoming report, which represents a year-over-year change of -73.6%. Revenues are expected to be $3.77 billion, down 14.8% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For U.S. Steel, the consensus EPS estimate for the quarter has been revised 26.1% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn&#39;t usually translate into price appreciation. So, make sure to keep an eye on X going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold).
U.S. Steel is a member of the Zacks Steel - Producers industry. One other stock in the same industry, Commercial Metals (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cmc#NYSE">CMC</a>), finished the last trading session 1% lower at $48.67. CMC has returned -8.3% over the past month.
Commercial Metals&#39; consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.14. Compared to the company&#39;s year-ago EPS, this represents a change of -32.5%. Commercial Metals currently boasts a Zacks Rank of #3 (Hold).
<a href="https://www.zacks.com/stock/news/2335003/u-s-steel-x-moves-7-0-higher-will-this-strength-last?cid=CS-BENZ-FT-tale_of_the_tape|daily_price_change_5%-2335003">To read this article on Zacks.com click here.</a>

Mid Cap

Events

U.S. Steel Moves 7.0% Higher: Will This Strength Last?

Cytek Biosciences shares are trading lower after COO Paul Christopher Williams submitted his resignation, effective Sept. 27.

Universe Pharmaceuticals Shares Resume Trade

Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Invesco S&amp;P 500 Equal Weight Health Care ETF (ARCA:RSPH) is a passively managed exchange traded fund launched on 11/01/2006.
Passively managed ETFs are becoming increasingly popular with institutional as well as retail investors due to their low cost, transparency, flexibility and tax efficiency. They are excellent vehicles for long term investors.
Sector ETFs are also funds of convenience, offering many ways to gain low risk and diversified exposure to a broad group of companies in particular sectors. Healthcare - Broad is one of the 16 broad Zacks sectors within the Zacks Industry classification. It is currently ranked 4, placing it in top 25%.
<h2>Index Details</h2>
The fund is sponsored by Invesco. It has amassed assets over $953.37 million, making it one of the larger ETFs attempting to match the performance of the Healthcare - Broad segment of the equity market. RSPH seeks to match the performance of the S&amp;P 500 EQUAL WEIGHT HEALTH CARE INDEX before fees and expenses.
The S&amp;P 500 Equal Weight Health Care Index equally weights stocks in the health care sector of the S&amp;P 500 Index.
<h2>Costs</h2>
Expense ratios are an important factor in the return of an ETF and in the long term, cheaper funds can significantly outperform their more expensive counterparts, other things remaining the same.
Annual operating expenses for this ETF are 0.40%, making it one of the cheaper products in the space.
It has a 12-month trailing dividend yield of 0.61%.
<h2>Sector Exposure and Top Holdings</h2>
ETFs offer a diversified exposure and thus minimize single stock risk but it is still important to delve into a fund&#39;s holdings before investing. Most ETFs are very transparent products and many disclose their holdings on a daily basis.
This ETF has heaviest allocation in the Healthcare sector--about 100% of the portfolio.
Looking at individual holdings, Bio-Rad Laboratories Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bio#NYSE">BIO</a>) accounts for about 1.82% of total assets, followed by Bristol-Myers Squibb Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bmy#NYSE">BMY</a>) and Gilead Sciences Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gild#NASDAQ">GILD</a>).
The top 10 holdings account for about 17.87% of total assets under management.
<h2>Performance and Risk</h2>
So far this year, RSPH has gained about 7.38%, and is up about 12.94% in the last one year (as of 09/12/2024). During this past 52-week period, the fund has traded between $25.30 and $32.39.
The ETF has a beta of 0.84 and standard deviation of 16.29% for the trailing three-year period. With about 65 holdings, it effectively diversifies company-specific risk.
<h2>Alternatives</h2>
Invesco S&amp;P 500 Equal Weight Health Care ETF carries a Zacks ETF Rank of 3 (Hold), which is based on expected asset class return, expense ratio, and momentum, among other factors. Thus, RSPH is a sufficient option for those seeking exposure to the Health Care ETFs area of the market. Investors might also want to consider some other ETF options in the space.
Vanguard Health Care ETF (ARCA:VHT) tracks MSCI US Investable Market Health Care 25/50 Index and the Health Care Select Sector SPDR ETF (ARCA:XLV) tracks Health Care Select Sector Index. Vanguard Health Care ETF has $18.69 billion in assets, Health Care Select Sector SPDR ETF has $41.93 billion. VHT has an expense ratio of 0.10% and XLV charges 0.09%.
<a href="https://www.zacks.com/stock/news/2335012/should-you-invest-in-the-invesco-s-p-500-equal-weight-health-care-etf-rsph?cid=CS-BENZ-FT-sector_etf-2335012">To read this article on Zacks.com click here.</a>

Large Cap

Sector ETFs

Dividends

Health Care

GILD

RSPH

Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF?

TJX Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>) has outperformed the market over the past 10 years by 3.96% on an annualized basis producing an average annual return of 14.68%. Currently, TJX Companies has a market capitalization of $132.91 billion. 
Buying $1000 In TJX: If an investor had bought $1000 of TJX stock 10 years ago, it would be worth $3,913.00 today based on a price of $117.39 for TJX at the time of writing.
<h3>TJX Companies's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726160510_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In TJX Companies 10 Years Ago Would Be Worth This Much Today

Cintas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) has outperformed the market over the past 5 years by 13.52% on an annualized basis producing an average annual return of 26.56%. Currently, Cintas has a market capitalization of $20.86 billion. 
Buying $100 In CTAS: If an investor had bought $100 of CTAS stock 5 years ago, it would be worth $328.00 today based on a price of $207.00 for CTAS at the time of writing.
<h3>Cintas's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726160505_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTAS

Here's How Much $100 Invested In Cintas 5 Years Ago Would Be Worth Today

EBAY

Live On CNBC, Josh Brown Discusses eBay With Al Michaels, American Sports Commentator; Shares See Volume To The Upside

Throughout the last three months, 4 analysts have evaluated Penske Automotive Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAG#NYSE">PAG</a>), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $160.25, a high estimate of $180.00, and a low estimate of $140.00. This upward trend is apparent, with the current average reflecting a 6.83% increase from the previous average price target of $150.00.
<img src="https://www.benzinga.com/files/images/story/2024/1726160463_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Penske Automotive Group. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jeff Lick</td>
<td>Stephens &amp; Co.</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$161.00</td>
<td>-</td>
</tr>
<tr>
<td>Rajat Gupta</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$160.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Rajat Gupta</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$140.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>John Murphy</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$180.00</td>
<td>$175.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Penske Automotive Group. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Penske Automotive Group compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Penske Automotive Group's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Penske Automotive Group's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PAG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Penske Automotive Group analyst ratings.</a>
<h2>Delving into Penske Automotive Group's Background</h2>
Penske Automotive Group operates in about 20 US states and overseas. It has over 150 US light-vehicle stores including in Puerto Rico as well as 210 franchised dealerships overseas, primarily in the United Kingdom but also in Australia, Continental Europe, and Japan. The company is the third-largest US-based dealership in terms of light-vehicle revenue and sells more than 40 brands, with over 90% of retail automotive revenue coming from luxury and import names. Other segments are service and finance and insurance. The firm's Premier Truck Group owns 48 truck dealerships selling mostly Freightliner and Western Star brands, and Penske owns over 10 used-vehicle stores in the US and UK under the CarShop (US) and Sytner Select (UK) brands. The company is based in Bloomfield Hills, Michigan,
<h3>Penske Automotive Group: A Financial Overview</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Positive Revenue Trend: Examining Penske Automotive Group's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 3.06% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Penske Automotive Group's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.13% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Penske Automotive Group's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.94% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Penske Automotive Group's ROA stands out, surpassing industry averages. With an impressive ROA of 1.47%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Penske Automotive Group's debt-to-equity ratio is below the industry average. With a ratio of 1.68, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Navigating 4 Analyst Ratings For Penske Automotive Group

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk may be ready to disrupt the traditional automotive assembly line manufacturing process with a new patent revealed ahead of the <a href="https://www.benzinga.com/news/24/09/40808924/tesla-robotaxi-event-to-be-held-in-los-angeles-on-1010-says-senior-company-exec-existing-shareholder">company's robotaxi day.</a>
What Happened: For years, Tesla has been one of the most innovative companies in the <a href="https://www.benzinga.com/electric-vehicles">electric vehicle sector </a>and its vertical integration methods and focus on production have helped the company achieve benefits in cost and scale.
The company could be ready to disrupt the traditional moving assembly line method used by automotive companies for over 100 years further with a new <a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2024182432&amp;_cid=P11-M0XZXF-23880-1">patent </a>showing its unboxed approach to manufacturing.
Unlike the traditional method of assembling pieces of a car together and passing them down the assembly line to complete a finished vehicle, the new method would allow Tesla to work on separate sections of the vehicle and then bring the pieces together at the end.
"A modular vehicle architecture for efficiently assembling vehicles. The modular vehicle architecture includes preparing a plurality of individual section of a vehicle in a plurality of sub-assembly lines prior to forming a full body frame of the vehicle," Tesla said in a patent with a publication date of June 9, 2024.
The patent references the front side, rear side, top side, bottom side, left side and right side as portions of the full body frame of the vehicle.
Tesla's patent says the normal manufacturing process moves the entire vehicle base to different areas for parts to be installed and for painting to occur.
"This traditional assembly process drives inefficiency in material handling and transport as the entire weight/footprint of the vehicle must be transported in order to assemble even small components."
In the patent, Tesla says "unboxing the assembly process" can improve speed in the manufacturing process.
Read Also: <a href="https://www.benzinga.com/news/earnings/24/07/39918390/tesla-q2-earnings-highlights-revenue-beat-eps-miss-robotaxi-update-2024-growth-rate-to-be-notably-l">Tesla Q2 Earnings Highlights: Revenue Beat, EPS Miss, Robotaxi Update, 2024 Growth Rate To Be &#8216;Notably Lower&#8217; Than 2023</a>
Why It's Important: Musk hinted at this<a href="https://www.benzinga.com/news/24/03/38000705/tesla-ceo-elon-musk-says-many-movies-celebrate-lone-inventors-eureka-moment-but-ignore-manufacturing"> new manufacturing process</a> in the past saying it could be faster and more efficient in making vehicles in the future.
The new process was reported to be part of the way for Tesla to get an electric vehicle to under the $25,000 price point, an item that has been delayed by the company.
With Tesla's robotaxi day scheduled for Oct. 10, all signs point to the robotaxi being the company's large focus and this new manufacturing patent could apply to that robotaxi vehicle.
Tesla could show off details of this manufacturing process during the robotaxi event.
While the new method abandons parts of the moving assembly line made famous by Henry Ford over 100 years ago, Musk and Tesla have been innovative in the production of electric vehicles. With scale and costs that other automotive companies are envious of, investors should be excited to see the new patent that could save costs and speed up the production methods for the company.
TSLA Price Action: Tesla shares were trading up 0.45% at $229.15 Thursday versus a 52-week trading range of $138.80 to $278.98. Tesla stock is down 8% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/09/40720928/elon-musk-to-unveil-reversible-seats-in-tesla-robotaxis-no-longer-a-driver-seat-in-the-vehicle">Elon Musk To Unveil Reversible Seats In Tesla Robotaxis? &#8216;No Longer A Driver Seat In The Vehicle&#8217;</a></li>
</ul>
Photo: Shutterstock

TSLA

Tesla Patent Shows New Automotive Assembly Process That Could Help Cut Costs: 'Efficiently Assembling Vehicles'

Across the recent three months, 9 analysts have shared their insights on Matador Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTDR#NYSE">MTDR</a>), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $80.78, a high estimate of $89.00, and a low estimate of $62.00. Experiencing a 0.88% decline, the current average is now lower than the previous average price target of $81.50. 
<img src="https://www.benzinga.com/files/images/story/2024/1726160449_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Matador Resources. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Zach Parham</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$76.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Hanwen Chang</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$89.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Scott Hanold</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$75.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Mike Scialla</td>
<td>Stephens &amp; Co.</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$81.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Subash Chandra</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$62.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Gabe Daoud</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$87.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$86.00</td>
<td>$91.00</td>
</tr>
<tr>
<td>Hanwen Chang</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$88.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Mike Scialla</td>
<td>Stephens &amp; Co.</td>
<td>Announces</td>
<td>Overweight</td>
<td>$83.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Matador Resources. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Matador Resources compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Matador Resources's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Matador Resources's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MTDR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Matador Resources analyst ratings.</a>
<h2>Get to Know Matador Resources Better</h2>
Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources. The majority of the company's assets are located in the United States, with an emphasis on oil and natural gas shale and other unconventional plays. Along with maintaining a portfolio of oil and natural gas properties, Matador works to identify and develop midstream opportunities that support and enhance its exploration and development business.
<h3>Breaking Down Matador Resources's Financial Performance</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Over the 3 months period, Matador Resources showcased positive performance, achieving a revenue growth rate of 31.59% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Energy sector.
Net Margin: Matador Resources's net margin excels beyond industry benchmarks, reaching 26.75%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Matador Resources's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.06% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Matador Resources's ROA stands out, surpassing industry averages. With an impressive ROA of 2.73%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.44, Matador Resources adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>How Are Analyst Ratings Determined?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MTDR

A Glimpse Into The Expert Outlook On Matador Resources Through 9 Analysts

Universe Pharmaceuticals Shares Resume And Halted To The Downside; Stock Now Down -49.34%

In the latest quarter, 9 analysts provided ratings for Murphy Oil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUR#NYSE">MUR</a>), showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Murphy Oil and provided 12-month price targets. The average target is $46.44, accompanied by a high estimate of $55.00 and a low estimate of $39.00. Observing a downward trend, the current average is 10.12% lower than the prior average price target of $51.67. 
<img src="https://www.benzinga.com/files/images/story/2024/1726160440_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Murphy Oil among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$39.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$41.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$44.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$47.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$45.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$46.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$55.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$54.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Paul Cheng</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Outperform</td>
<td>$47.00</td>
<td>$50.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Murphy Oil. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Murphy Oil compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Murphy Oil's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Murphy Oil's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/MUR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Murphy Oil analyst ratings.</a>
<h2>Delving into Murphy Oil's Background</h2>
Murphy Oil is an oil and gas exploration and production company, with both onshore and offshore operations and properties. It operates in two geographic reportable segments the United States and Canada. It generates the majority of its revenue form the United States.
<h3>Breaking Down Murphy Oil's Financial Performance</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Murphy Oil's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -1.46%. This indicates a decrease in the company's top-line earnings. When compared to others in the Energy sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Murphy Oil's net margin is impressive, surpassing industry averages. With a net margin of 15.95%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Murphy Oil's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.4%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Murphy Oil's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.31%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Murphy Oil's debt-to-equity ratio is below the industry average at 0.41, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Evaluating Murphy Oil: Insights From 9 Financial Analysts

In the latest quarter, 4 analysts provided ratings for Designer Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBI#NYSE">DBI</a>), showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Designer Brands, revealing an average target of $7.62, a high estimate of $10.00, and a low estimate of $5.50. A decline of 21.85% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1726160428_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of Designer Brands by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$5.50</td>
<td>$9.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$6.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$10.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$9.00</td>
<td>$10.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Designer Brands. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Designer Brands compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Designer Brands's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DBI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Designer Brands analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Discovering Designer Brands: A Closer Look</h2>
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment, and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.
<h3>Designer Brands: A Financial Overview</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Designer Brands's revenue growth over a period of 3 months has been noteworthy. As of 30 April, 2024, the company achieved a revenue growth rate of approximately 0.61%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.
Net Margin: Designer Brands's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 0.1%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Designer Brands's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 0.22%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Designer Brands's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.04%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Designer Brands's debt-to-equity ratio surpasses industry norms, standing at 3.61. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Decoding 4 Analyst Evaluations For Designer Brands

Applied Industrial Techs's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIT#NYSE">AIT</a>) short percent of float has fallen 13.5% since its last report. The company recently reported that it has 618 thousand shares sold short, which is 2.37% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.26 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Applied Industrial Techs Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726160421_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Applied Industrial Techs has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Applied Industrial Techs's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Applied Industrial Techs's peer group average for short interest as a percentage of float is 4.49%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Applied Industrial Techs?

David Herro's International Equity Market Commentary - Q3 2023

Q3 2023 Equity Factor Report: Value Strategies Rally As Bullish Sentiment Dampens

A Disjointed World: Themes For 2024

Xtrackers FTSE Developed ex US Multifactor ETF declares quarterly distribution of $0.1846

Above The Noise: Anticipating A New Year And A New Market Environment

Q4 2023 - International Equity Review And Outlook

Xtrackers FTSE Developed ex US Multifactor ETF declares quarterly distribution of $0.0653

Xtrackers FTSE Developed ex US Multifactor ETF declares quarterly distribution of $0.4105

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Xtrackers FTSE Developed ex US Multifactor ETF

News

Latest news for Xtrackers FTSE Developed ex US Multifactor ETF (ARCA:DEEF)

Wednesday, June 29, 2016

Wednesday, April 20, 2016

Tuesday, December 08, 2015